Single-Dose, Randomized, Open-Label, Two-Way, Crossover Bioequivalence Study of Two Formulations of Pregabalin 300 mg Hard Capsules in Healthy Volunteers Under Fasting Conditions
Crossref DOI link: https://doi.org/10.1007/s40268-015-0094-8
Published Online: 2015-05-05
Published Print: 2015-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Filipe, Augusto
Almeida, Susana
Pedroso, Pedro Filipe
Neves, Rita
Marques, Susana
Sicard, Eric
Massicotte, Julie
Ortuño, Jordi
License valid from 2015-05-05